1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Germany Neurodiagnostics Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in Germany Neurodiagnostics Market
4. Germany Neurodiagnostics Market by
Technology Type
4.1. Neuroimaging
4.1.1. Nuclear Medicine Imaging
4.1.2. Electro-encephalography
4.1.3. Magneto-encephalography
4.1.4. Other Neuroimaging Technologies
4.2. in Vitro Diagnosis
4.2.1. Genetic Testing
4.2.2. Protein Biomarker Assay
4.2.3. Other in Vitro Diagnosis
4.3. Neuroinformatics
5. Germany Neurodiagnostics Market by
Disease Type
5.1. Migraine
5.2. Multiple Sclerosis
5.3. Alzheimer’s Disease
5.4. Parkinson’s Disease
5.5. Depression
5.6. Other Diseases
6. Germany Neurodiagnostics Market by
End-user
6.1. Neurology Centers
6.2. Diagnostic Laboratories and Imaging Centers
6.3. Hospitals and Surgical Centers
6.4. Ambulatory Care Centers
6.5. Research Laboratories
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Germany Neurodiagnostics Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in Germany Neurodiagnostics Market
4. Germany Neurodiagnostics Market by
Technology Type
4.1. Neuroimaging
4.1.1. Nuclear Medicine Imaging
4.1.2. Electro-encephalography
4.1.3. Magneto-encephalography
4.1.4. Other Neuroimaging Technologies
4.2. in Vitro Diagnosis
4.2.1. Genetic Testing
4.2.2. Protein Biomarker Assay
4.2.3. Other in Vitro Diagnosis
4.3. Neuroinformatics
5. Germany Neurodiagnostics Market by
Disease Type
5.1. Migraine
5.2. Multiple Sclerosis
5.3. Alzheimer’s Disease
5.4. Parkinson’s Disease
5.5. Depression
5.6. Other Diseases
6. Germany Neurodiagnostics Market by
End-user
6.1. Neurology Centers
6.2. Diagnostic Laboratories and Imaging Centers
6.3. Hospitals and Surgical Centers
6.4. Ambulatory Care Centers
6.5. Research Laboratories
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5